“dQ&A has large numbers of diabetes, T2D and insulin patients at their disposal as well as other customers and understands diabetes as well, if not better, than we do.”
Suggested Articles
Endocrinologist Perspectives: Oral and Injectable Therapies
dQ&A conducted another wave of our Endocrinologist Perspectives research with n=190 endocrinologists across private offices, hospitals, community clinics, and managed care organizations. Results indicated that…
dQ&A® and CeQur Publication Featured in Clinical Diabetes
Transition to the SIP…
Findings from Diabetes Technology in Primary Care Research
In December 2022…
